Accessibility

Accessibility Statement

 
Introduction
The internet today constitutes the largest database of free information for all users, including users with disabilities. As such, we place great emphasis on providing equal opportunity for people with disabilities to be able to use the information on our website and enjoy a better browsing experience. 
We aim to ensure that digital services are accessible to people with disabilities, and therefore we have invested large resources in order to simplify the use of the website for people with disabilities as much as possible, out of the belief that every person deserves the right to live with equality, dignity, convenience, and independence. 
 
Using the website accessibility program
This website is run by the accessibility program of the "Accessible with a Click" company and is run via a designated accessibility server. The program allows the website to follow the guidelines for internet content accessibility WCAG 2.0 to level AA. The program is subject to the conditions of use of the manufacturer. Warrantee of use applies to the website owners and/or their representative, including the content displayed in the website, as subject to the conditions of use. 
 
How does accessibility work on the website?

The website has an accessibility menu. Clicking on the menu opens accessibility buttons. After choosing a subject in the menu, waiting time is necessary for the page to upload. 

What is in the menu?

 

✓ Ability to navigate with the keyboard
✓ Increasing and decreasing the website fonts
✓ Changing color contrast based on dark backgrounds
✓ Changing color contrast based on light backgrounds
✓ Adapting the website to color blind people
✓ Underlining links throughout the website

 

Clarification

Despite our efforts to enable website browsing for all the website pages, there may be website pages that haven't been made accessible yet or may lack a suitable technical solution.
We are continuing our efforts to enhance the accessibility of the website as much as possible, out of our moral obligation to enable the use of the website for the population as a whole, including people with disabilities. 
Alomone Labs Alomone Labs

Order Summary

Sign In

Forgot your password?

New customer? Create an account
Home

main

    • column
      • Ion Channels
    • column
      • G-Protein Coupled Receptors
      • Transporters, Exchangers and Pumps
    • column
      • Neurotrophic Factors and Receptors
      • Neural Signaling
    • column
      • Cell Imaging Tools
      • Research Areas
  • Home
  • Products
    • column
      • New Products
      • All Products
      • Research Areas
      • Select Targets
    • column
      • Ion Channels
      • G-Protein Coupled Receptors
      • Transporters, Exchangers and Pumps
      • Kits & Packs
    • column
      • Neurotrophic Factors and Receptors
      • Neural Signaling
      • Cell Imaging Tools
    • column
      • Guinea Pig Polyclonal Antibodies
      • Immuno-Colocalization Products
      • Live Cell Imaging Products
      • Live Cell Flow Cytometry Products
  • News & Updates
    • column
      • Magazines
      • Featured Papers
    • column
      • Immuno-Colocalization Updates
      • Live Cell Imaging Updates
  • Service & Support
    • column
      • Service & Support
      • Ordering & Shipping
      • Free Sample Program
    • column
      • Protocols
      • FAQs
      • Alomone Guarantee
  • About
    • column
      • About Alomone Labs
      • Why Alomone Labs?
  • Contact
    • column
      • Contact Us
      • Subscribe – Newsletters and Email Updates
      • Subscribe – Printed Magazines
Return to Content
Home › Products › Ion Channels › K+ Channels › Inward Rectifier K+ Channels › Blockers

Certificate of Analysis

Tertiapin-Q-ATTO-488
In wishlist

An Inward Rectifier K+ Channel Blocker Conjugated to the Fluorescent Dye ATTO-488
    Cat #: STT-170-AG
  • Lyophilized Powder
    Lyophilized Powder

    This product is freeze dried. All water molecules have been removed.

  • Bioassay Tested
    Bioassay Tested

    Every lot is tried & tested in a relevant biological assay.
    Our Bioassay

    • Origin Synthetic peptide
    MW: 3195.5 Da.
    Purity: >95%
    Effective concentration 50-200 nM.
    Modifications Disulfide bonds between Cys3-Cys14, Cys5-Cys18. Lys21 - C-terminal amidation.
    Label ATTO-488. ATTO dyes are characterized by strong absorption (high extinction coefficient), high fluorescence quantum yield, and high photo-stability. ATTO-488 maximum absorption is 501 nm and maximum fluorescence is at 523 nm. The fluorescence is excited most efficiently in the 480 - 515 nm range. This label is analogous to the well known dye fluorescein isothiocyanate (FITC) and can be used with filters typically used to detect FITC. The extent of labeling is one molecule of dye per molecule of Tertiapin-Q.
    Structure
    • Tertiapin-Q-ATTO-488
    Activity Tertiapin-Q blocks a range of inward rectifier K+ channels (Kir), in particular ROMK1 and GIRK, but with no effect on Kir2 family members1,2. In addition, it was shown to inhibit acetylcholine induced K+ currents in the heart3,4.
    References-Activity
    1. Jin, W. and Lu, Z. (1998) Biochemistry 37, 13291.
    2. Jin, W. et al. (1999) Biochemistry 38, 14294.
    3. Drici, M.D. et al. (2000) Br. J. Pharmacol. 131, 569.
    4. Kitamura, H. et al. (2000) Pharmacol. Exp. Therap. 293, 196.
    Shipping and storage Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C. Avoid exposure to light.
    Solubility Any aqueous buffer. Centrifuge all product preparations before use (10000 x g 5 min). Avoid exposure to light. The product is lyophilized in 0.5 ml conical vial.
    Storage of solutions Up to two weeks at 4°C or three months at -20°C. Avoid exposure to light.
    Our bioassay
    • Tertiapin-Q-ATTO-488
      Alomone Labs Tertiapin-Q-ATTO-488 inhibits Kir3.2 channels heterologously expressed in Xenopus oocytes.
      A continuous current trace recorded at a holding potential of -80 mV. Kir3.2 currents are downward reflections activated by high K+ containing solution. While activated, 50 nM and 100 nM of Tertiapin-Q-ATTO-488 (#STT-170-AG) were applied for 2 min (indicated as bars).
    • Tertiapin-Q-ATTO-488
      Alomone Labs Tertiapin-Q-ATTO-488 binds GIRK1/4-Cherry transfected HEK293T cells.
      Transfected cells were incubated in the presence of 200 nM Tertiapin-Q-ATTO-488 (#STT-170-AG). The labeled toxin accumulates on the membrane surface after 26 sec. No binding is achieved in untransfected cells (data not shown).
      The pictures are a kind gift from the lab of Prof. Eithan Reuveny, Weizmann Institute, Israel.
    Scientific background

    Tertiapin, the native toxin, was originally isolated from European honey bee Apis mellifera venom. Native and synthetic Tertiapin blocks a range of inward rectifier K+ channels (Kir), in particular ROMK1 (Kir1.1, IC50 = 2 nM) and GIRK (Kir3 family, IC50 for the Kir3.1/3.4 heteromer was 8.6 nM) but with no effect on the Kir2 family member1. In accordance, it was shown to inhibit acetylcholine induced K+ currents in mammalian cardiomyocytes2,3.

    Tertiapin-Q is a derivative of Tertiapin in which Met13 is substituted by a Gln residue. However, unlike native Tertiapin, Tertiapin-Q is non-oxidizable and therefore is more stable4.

    Tertiapin-Q inhibits the above-mentioned channels with similar affinities and also inhibits Ca2-activated large conductance BK-type K+ channels in a concentration and voltage-dependent manner5.

    Target Kir1.1, Kir3.2 K+ channels
    Net Peptide Content: 100%
    Lyophilized Powder
    Back to product page
    Image & Title

    Tertiapin-Q-ATTO-488Double staining of GIRK2 channels in substantia nigra pars compacta using Tertiapin-Q-ATTO-488 and Guinea pig Anti-GIRK2 (Kir3.2) Antibody.Rat brain sections were first incubated with 33 nM Tertiapin-Q-ATTO-488 (#STT-170-AG), (green). The same sections were incubated with Guinea pig Anti-GIRK2 (Kir3.2) Antibody (#AGP-013). A. Tertiapin-Q-ATTO-488 binding appears in profiles of substantia nigra pars compacta (SNC) neurons (arrows). B. GIRK2 staining (red) is detected in profiles of SNC neurons (arrows). C. Merge of the two images demonstrates co-staining of GIRK2 channels by Tertiapin-Q-ATTO-488 and by Guinea pig Anti-GIRK2 (Kir3.2) Antibody. DAPI staining (blue) is used to stain nuclei.

    Last update: 24/01/2020
    For research purposes only, not for human use

    Specifications

    Applications

    Scientific Background

    Citations

    Citations
    Shipping and Ordering information
    In Stock
    Size
    Qty
    Price (USD):
      Back to product page

      Files

      • SDS

      Shipping Information

      Products are lyophilized and ship at room temperature.

      We ship worldwide within 24 hours of our next business day.

      For more country-specific shipping and contact information see Ordering & Shipping.

      Free Sample Program

      Not sure whether the product fits your experimental setup?

      Try it first!

      Alomone Guarantee

      We offer 100% guarantee on all our products. If our products do not perform as stated, please contact our technical support staff.

      Alomone Guarantee information

      Need Help With This Product?

      Our reagent specialists are here to help you find the best product for your application. Please call or email us and we will be happy to help you find the right product for the job.

      Call us at
      +972 2587 2202 or Email Us

      Contact Us

      © 2020 Alomone Labs. All Rights Reserved.

      Terms of Service Privacy Policy
      Scroll to top